Personalized Care
Personalized Care
批准号:
8898428
负责人:
TODD M HULGAN
金额:
$5.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2016-04-30
关键词:
AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAgreementApplications GrantsAreaAuthorshipAwardBiometryBiostatistics CoreCaringCenter for Translational Science ActivitiesCenters for Disease Control and Prevention (U.S.)Clinical InvestigatorClinical ResearchCommunitiesContinuity of Patient CareDataDatabasesDevelopmentEnvironmentFosteringFundingGoalsGrantGroup MeetingsHIVHealthHealth PolicyIndividualInformaticsInstitutesInstitutionInternationalInterventionJointsLaboratory ScientistsLeadershipMentorsMentorshipMethodsMissionOutcome MeasurePerformancePopulationProcessProtocols documentationPublic HealthPublicationsPublishingResearchResearch PersonnelResearch PriorityResourcesScheduleTennesseeTimeTranslational ResearchUnited States National Institutes of HealthWorkbiomedical informaticsclinical carecommunity planningdesignglobal healthhealth disparityimplementation researchimprovedinnovationinterestmeetingsmembernext generationpersonalized careprogramsworking group
中文摘要
SWG-项目摘要
田纳西州CFAR(TN-CFAR)科学工作组将由以下成员组成
在科学发现、临床护理、公共卫生、生物统计学、信息学和社区方面的专业知识
参与,并将利用伙伴机构的优势。最初的SWGs-艾滋病毒护理的连续体
和个性化艾滋病毒护理-被确定为利用这些优势和
地方资源,并使我们的CFAR在实地产生最大的影响。这些SWG具有协同性
在人口和个人层面改善艾滋病毒护理的目标,并将推动研究和实施
为TN-CFAR使命做出贡献的战略,以在我们的机构提供艾滋病毒/艾滋病研究领导,
指导下一代艾滋病毒研究人员,最终减轻艾滋病毒/艾滋病的负担。的具体目标
这两个SWG将(1)连接临床研究人员、实验室科学家、公共卫生从业者,以及
社区利益攸关方;以及(2)培养跨机构和跨学科的礼宾团队,以
实施和完成协作研究,解决每个领域的关键问题。这些目标将是
通过每个SWG共同的流程实现,这些流程将由管理核心监督,以及
针对每个SWG的几个计划和子目标。发展下一代艾滋病毒/艾滋病
调查人员,两个SWG都将实施专门为吸引新人和初级人员而设计的流程
调查人员,将提供一个促进有效指导的环境,并将确保每个
新手/初级调查员有一位特定的导师。这些SWG将高度受数据驱动,与
行政核心和生物统计和生物医学信息学核心开发RedCap数据库
收集和发布SWG性能的实时数据。最重要的结果衡量标准之一
将是:1)具有跨机构、跨学科作者的高影响力出版物;以及2)新的赠款
提交和奖励是跨机构和跨学科的。收集的其他数据和
评估将包括所有三个合作机构和社区利益攸关方的参与程度,
新的和初级的调查员,以及为初级调查员确定的导师。每个SWG都包括一个创新的
由一名有指导的初级调查员领导的概念项目将在TN-CFAR的第一年启动。
英文摘要
SWG - PROJECT SUMMARY
The Tennessee CFAR (TN-CFAR) Scientific Working Groups (SWGs) will be comprised of members with
expertise in scientific discovery, clinical care, public health, biostatistics, informatics, and community
engagement, and will leverage strengths of the partner institutions. The initial SWGs—Continuum of HIV Care
and Personalized HIV Care—were identified as high-priority areas that take advantage of these strengths and
local resources, and to allow our CFAR to have the greatest impact on the field. These SWGs have synergistic
goals to improve HIV care on the population and individual level, and will drive research and implementation
strategies to contribute to the TN-CFAR mission to provide HIV/AIDS research leadership at our institutions,
mentor the next generation of HIV researchers, and ultimately reduce the burden of HIV/AIDS. Specific Aims of
both SWGs will be to (1) connect clinical investigators, laboratory scientists, public health practitioners, and
community stakeholders; and (2) nurture trans-institutional and trans-disciplinary protocol teams that
implement and complete collaborative research addressing critical questions in each area. These Aims will be
achieved through processes common to each SWG that will be overseen by the Administrative Core, and
several initiatives and Sub-aims specific to each SWG. To develop the next generation of HIV/AIDS
investigators, both SWGs will implement processes specifically designed to attract new and junior
investigators, will provide an environment that fosters effective mentorship, and will assure that each
new/junior investigator has a specific mentor. These SWGs will be highly data-driven, working with the
Administrative Core and the Biostatistics and Biomedical Informatics Core to develop REDCap databases to
collect and disseminate real-time data on SWG performance. Among the most important outcome measures
will be: 1) high impact publications with trans-institutional, trans-disciplinary authorship; and 2) new grant
submissions and awards that are trans-institutional and trans-disciplinary. Additional data collected and
evaluated will include extent of engagement from all three partner institutions and community stakeholders,
new and junior investigators, and mentors identified for junior investigators. Each SWG includes an innovative
concept project led by a mentored junior investigator to be initiated in Year 1 of the TN-CFAR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the Contribution of Mitochondrial DNA to Viral Infectious Diseases, Type 2 Diabetes, and their Interactions
-
批准号:10589249
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8458599
-
项目类别:
-
资助金额:$63.8万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8845250
-
项目类别:
-
资助金额:$46.29万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8294542
-
项目类别:
-
资助金额:$68.71万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8896116
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8658731
-
项目类别:
-
资助金额:$52.17万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8210312
-
项目类别:
-
资助金额:$69.86万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Mitochondrial Genomics and Effects of Cocaine on T cells during HIV-Infection
-
批准号:8112582
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2010
-
负责人:TODD M HULGAN
-
依托单位:
Mitochondrial Genomics and Effects of Cocaine on T cells during HIV-Infection
-
批准号:7931761
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2010
-
负责人:TODD M HULGAN
-
依托单位:
Mitochondrial Genomics and Peripheral Neuropathy during HIV Therapy
-
批准号:7284699
-
项目类别:
-
资助金额:$26.83万
-
财政年份:2007
-
负责人:TODD M HULGAN
-
依托单位:
Mitochondrial Genomics and Peripheral Neuropathy during HIV Therapy
-
批准号:7383762
-
项目类别:
-
资助金额:$15.35万
-
财政年份:2007
-
负责人:TODD M HULGAN
-
依托单位:
LIPOATROPHY AND NEUROPATHY COHORT (LINC) STUDY
-
批准号:7605644
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2006
-
负责人:TODD M HULGAN
-
依托单位:
LIPOATROPHY AND NEUROPATHY COHORT (LINC) STUDY
-
批准号:7731468
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2006
-
负责人:TODD M HULGAN
-
依托单位:
Oxidant Stress and Antioxidants during HIV Therapy
-
批准号:6946518
-
项目类别:
-
资助金额:$11.83万
-
财政年份:2004
-
负责人:TODD M HULGAN
-
依托单位:
Oxidant Stress and Antioxidants during HIV Therapy
-
批准号:7070633
-
项目类别:
-
资助金额:$11.83万
-
财政年份:2004
-
负责人:TODD M HULGAN
-
依托单位:
Oxidant Stress and Antioxidants during HIV Therapy
-
批准号:6844402
-
项目类别:
-
资助金额:$11.8万
-
财政年份:2004
-
负责人:TODD M HULGAN
-
依托单位:
海外基金